These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
54. Paring down the company: the effect of consolidation in the European biotech sector. Bassett P Nat Biotechnol; 2003 Jul; 21(7):829-30. PubMed ID: 12833105 [No Abstract] [Full Text] [Related]
55. On the road to California. DeWitt N Nature; 2002 Dec; 420(6916 Suppl):A9. PubMed ID: 12510695 [No Abstract] [Full Text] [Related]
56. Biopharma business models in Canada. March-Chordà I; Yagüe-Perales RM Drug Discov Today; 2011 Aug; 16(15-16):654-8. PubMed ID: 21708279 [TBL] [Abstract][Full Text] [Related]
59. A time for growth: an interview with Amgen CEO Kevin Sharer. Interview by Paul Hemp. Sharer K Harv Bus Rev; 2004; 82(7-8):66-74, 186. PubMed ID: 15241953 [TBL] [Abstract][Full Text] [Related]